+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Renal Denervation Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 76 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5459963
Renal Denervation Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Summary


This Medical Devices sector report, “Renal Denervation Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Renal Denervation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Renal Denervation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Renal Denervation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Renal Denervation Catheters Overview
3 Products under Development
3.1 Renal Denervation Catheters - Pipeline Products by Stage of Development
3.2 Renal Denervation Catheters - Pipeline Products by Segment
3.3 Renal Denervation Catheters - Pipeline Products by Territory
3.4 Renal Denervation Catheters - Pipeline Products by Regulatory Path
3.5 Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
3.6 Renal Denervation Catheters - Ongoing Clinical Trials
4 Renal Denervation Catheters - Pipeline Products under Development by Companies
4.1 Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
4.2 Renal Denervation Catheters - Pipeline Products by Stage of Development
5 Renal Denervation Catheters Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Ablative Solutions Inc Company Overview
5.2.1 Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 AngioCare BV Company Overview
5.3.1 AngioCare BV Pipeline Products & Ongoing Clinical Trials Overview
5.4 Brattea Company Overview
5.4.1 Brattea Pipeline Products & Ongoing Clinical Trials Overview
5.5 CryoMedix, LLC. Company Overview
5.5.1 CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Handok-Kalos Medical Company Overview
5.6.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
5.7 Johns Hopkins University Company Overview
5.7.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Kona Medical Inc Company Overview
5.8.1 Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Lepu Medical Technology (Beijing) Co Ltd Company Overview
5.9.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.10.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Mayo Clinic Company Overview
5.11.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.12 Medtronic Plc Company Overview
5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.13 MicroPort Scientific Corp Company Overview
5.13.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Northwind Medical Inc Company Overview
5.14.1 Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 ReCor Medical Inc Company Overview
5.15.1 ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Renal Dynamics, LLC Company Overview
5.16.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Renaly Ltd Company Overview
5.17.1 Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
5.18.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 Shanghai Golden Leaf Medtech Co Ltd Company Overview
5.19.1 Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 SoniVie Inc Company Overview
5.20.1 SoniVie Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Sound Interventions, Inc. Company Overview
5.21.1 Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.22 St. Jude Medical LLC Company Overview
5.22.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 Suzhou SyMap Medical Ltd Company Overview
5.23.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 Symple Surgical Inc Company Overview
5.24.1 Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Tel Aviv University Company Overview
5.25.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Terumo Interventional Systems Company Overview
5.26.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.27 University of Sydney Company Overview
5.27.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
5.28 Verve Medical, Inc. Company Overview
5.28.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Renal Denervation Catheters- Recent Developments
6.1 Sep 21, 2021: PAVmed subsidiary Veris Health joins Microsoft for startups global program and engages Loka as software development partner
6.2 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.3 Aug 12, 2021: PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
6.4 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.5 Aug 02, 2021: PAVmed to Hold Business Update Conference Call on August 12, 2021
6.6 Jul 28, 2021: Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors
6.7 Jun 14, 2021: Tim Baxter Joins PAVmed Board of Directors
6.8 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.9 May 17, 2021: PAVmed Provides Business Update and First Quarter 2021 Financial Results
6.10 May 06, 2021: PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
6.11 May 03, 2021: PAVmed to Hold Business Update Conference Call on May 17 2021
6.12 Apr 29, 2021: Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
6.13 Apr 27, 2021: Global Industry Executive Debbie White Joins PAVmed Board of Directors
6.14 Feb 18, 2021: PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
6.15 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.16 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.17 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.18 Feb 09, 2021: PAVmed to Hold Business Update Conference Call on February 22, 2021
6.19 Feb 04, 2021: Terumo announce Financial Statements
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Renal Denervation Catheters - Pipeline Products by Stage of Development
  • Renal Denervation Catheters - Pipeline Products by Segment
  • Renal Denervation Catheters - Pipeline Products by Territory
  • Renal Denervation Catheters - Pipeline Products by Regulatory Path
  • Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
  • Renal Denervation Catheters - Ongoing Clinical Trials
  • Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
  • Renal Denervation Catheters - Pipeline Products by Stage of Development
  • Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Chemical RDN System - Product Status
  • Chemical RDN System - Product Description
  • Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Peregrine System Kit - Hypertension - Product Status
  • Peregrine System Kit - Hypertension - Product Description
  • Ablative Solutions Inc - Ongoing Clinical Trials Overview
  • Peregrine System Kit - Hypertension - A Phase II, Multicenter, Blinded, Sham Procedure-controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension, in the Absence of Antihypertensive Medications
  • Peregrine System Kit - Hypertension - A Pivotal, Multicenter, Blinded, Sham procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension
  • AngioCare BV Pipeline Products & Ongoing Clinical Trials Overview
  • Allegro Renal Denervation System - Product Status
  • Allegro Renal Denervation System - Product Description
  • Brattea Pipeline Products & Ongoing Clinical Trials Overview
  • 6-Electrode Ablation Catheter - Product Status
  • 6-Electrode Ablation Catheter - Product Description
  • CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • Catheter Based Cryoablation System - Product Status
  • Catheter Based Cryoablation System - Product Description
  • Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
  • DENEX - Product Status
  • DENEX - Product Description
  • Handok-Kalos Medical - Ongoing Clinical Trials Overview
  • DENEX - A Prospective, Multicenter, No-treatment Controlled, Randomized, Open-label, Pivotal Study to Evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in Patients with Hypertension on no or 1-3 Antihypertensive Medications
  • DENEX - A Prospective, Multicenter, Sham-controlled, Single-blinded, Randomized, Pilot Study to Evaluate the Safety and Effectiveness of DENEX Renal Denervation System in Patients with Uncontrolled Hypertension Not Treated with Antihypertensive Medication
  • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Flexible Renal Denervation Ablation Device - Product Status
  • Flexible Renal Denervation Ablation Device - Product Description
  • Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Surround Sound System - Product Status
  • Surround Sound System - Product Description
  • Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Renal Denervation System - Product Status
  • Renal Denervation System - Product Description
  • Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Renal Denervation Catheter - Product Status
  • Renal Denervation Catheter - Product Description
  • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • Pressure Wire - Product Status
  • Pressure Wire - Product Description
  • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Symplicity Spyral Renal Denervation Catheter - Product Status
  • Symplicity Spyral Renal Denervation Catheter - Product Description
  • Medtronic Plc - Ongoing Clinical Trials Overview
  • Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation in the Distal Main and First Order Branch Renal Arteries Using the Symplicity Spyral Multi-electrode Renal Denervation System (SPYRAL DYSTAL)
  • Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension in the Absence of Antihypertensive Medications: SPYRAL PIVOTAL - SPYRAL HTN-OFF MED
  • Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
  • Symplicity Spyral Renal Denervation Catheter - Prairie Renal Denervation Study: Renal Denervation (RDN) for Management of Patients with Loin Pain Hematuria Syndrome (LPHS)
  • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • FlashPoint Renal Artery RF Ablation Catheter - Product Status
  • FlashPoint Renal Artery RF Ablation Catheter - Product Description
  • Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Guidewire Based Catheter - Product Status
  • Guidewire Based Catheter - Product Description
  • ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • PARADISE Renal Denervation System - Product Status
  • PARADISE Renal Denervation System - Product Description
  • ReCor Medical Inc - Ongoing Clinical Trials Overview
  • PARADISE Renal Denervation System - A Clinical Study of the Ultrasound Renal Denervation System in Patients with Resistant Hypertension
  • PARADISE Renal Denervation System - A Study of the ReCor Medical Paradise System in Clinical Hypertension: The RADIANCE-HTN Study
  • PARADISE Renal Denervation System - Clinical Study of an Ultrasound Renal Denervation System in Patients with Heart Failure
  • PARADISE Renal Denervation System - Radiance Trio Continued Access Protocol (TRIO CAP): A Study of the ReCor Medical Paradise System in Clinical Hypertension
  • PARADISE Renal Denervation System - The Global Paradise System Registry
  • PARADISE Renal Denervation System - The Radiance II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
  • Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • ReDy Renal Denervation System - Product Status
  • ReDy Renal Denervation System - Product Description
  • Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Renal Artery Denervation System - Product Status
  • Renal Artery Denervation System - Product Description
  • Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Iberis Second-Generation Renal Sympathetic Denervation System - Product Status
  • Iberis Second-Generation Renal Sympathetic Denervation System - Product Description
  • Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Renal Denervation System - Hypertension - Product Status
  • Renal Denervation System - Hypertension - Product Description
  • SoniVie Inc Pipeline Products & Ongoing Clinical Trials Overview
  • TIVUS System - Renal Artery Denervation - Product Status
  • TIVUS System - Renal Artery Denervation - Product Description
  • Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Ultrasound Renal Denervation System - Product Status
  • Ultrasound Renal Denervation System - Product Description
  • St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Third Generation EnligHTN Renal Denervation System - Product Status
  • Third Generation EnligHTN Renal Denervation System - Product Description
  • Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • SyMapCath I Catheter - Product Status
  • SyMapCath I Catheter - Product Description
  • Suzhou SyMap Medical Ltd - Ongoing Clinical Trials Overview
  • SyMapCath I Catheter - A Prospective, Multicenter, Blind, Randomized and Controlled Trial of Selected Renal Denervation by Renal Nerve Mapping for the Treatment of Hypertension (HTN) in the Absence of Antihypertensive Medications (OFF MED)
  • SyMapCath I Catheter - A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial)
  • SyMapCath I Catheter - A Prospective, Single-center, Open-label, Self-Controlled Case Series Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension in Patients on Hemodialysis: SMART-HD Trial
  • Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • DirectAblate Renal Denervation System - Product Status
  • DirectAblate Renal Denervation System - Product Description
  • Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • Catheter System - Arterial Stiffness - Product Status
  • Catheter System - Arterial Stiffness - Product Description
  • Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
  • Renal Sympathetic Denervation System - TRI Technique - Product Status
  • Renal Sympathetic Denervation System - TRI Technique - Product Description
  • University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
  • Mu Catheter - Product Status
  • Mu Catheter - Product Description
  • Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Verve Medical System - Product Status
  • Verve Medical System - Product Description
  • Glossary

List of Figures
  • Renal Denervation Catheters - Pipeline Products by Stage of Development
  • Renal Denervation Catheters - Pipeline Products by Segment
  • Renal Denervation Catheters - Pipeline Products by Territory
  • Renal Denervation Catheters - Pipeline Products by Regulatory Path
  • Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
  • Renal Denervation Catheters - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Vascular Inc
  • Ablative Solutions Inc
  • AngioCare BV
  • Brattea
  • CryoMedix, LLC.
  • Handok-Kalos Medical
  • Johns Hopkins University
  • Kona Medical Inc
  • Lepu Medical Technology (Beijing) Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Mayo Clinic
  • Medtronic Plc
  • MicroPort Scientific Corp
  • Northwind Medical Inc
  • ReCor Medical Inc
  • Renal Dynamics, LLC
  • Renaly Ltd
  • Shanghai Bio-heart Biological Technology Co Ltd
  • Shanghai Golden Leaf Medtech Co Ltd
  • SoniVie Inc
  • Sound Interventions, Inc.
  • St. Jude Medical LLC
  • Suzhou SyMap Medical Ltd
  • Symple Surgical Inc
  • Tel Aviv University
  • Terumo Interventional Systems
  • University of Sydney
  • Verve Medical, Inc.